FGFR4 inhibitor monoclonal antibody

This page covers all FGFR4 inhibitor monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting FGFR4 (Fibroblast Growth Factor Receptor 4).

Targets

FGFR4 (Fibroblast Growth Factor Receptor 4)

Phase 3 pipeline (1)

• BION-1301 · Chinook Therapeutics, Inc. · Oncology
  BION-1301 is a monoclonal antibody that targets and inhibits FGFR4 (fibroblast growth factor receptor 4) to reduce hepatocellular carcinoma cell growth and survival.

Patent intelligence

• fgfr4 inhibitor monoclonal antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates